
IPATF
Healthcare · Biotechnology · $313.3M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Dec 21, 2020 | Time not confirmed | -0.02 | -0.03 | -50.0% |
| Aug 28, 2020 | Time not confirmed | — | -0.05 | — |
| Mar 10, 2020 | Time not confirmed | — | -0.01 | — |
| Dec 17, 2019 | Time not confirmed | — | -0.02 | — |
| Aug 28, 2019 | Time not confirmed | -0.05 | -0.30 | -500.0% |
| Mar 27, 2019 | Time not confirmed | -0.10 | -0.05 | +50.0% |
| Dec 28, 2018 | Time not confirmed | -0.10 | -0.10 | 0.0% |
| Aug 28, 2018 | Time not confirmed | — | -0.02 | — |
| Apr 30, 2018 | Time not confirmed | — | -0.16 | — |
| Jan 31, 2018 | Time not confirmed | — | -0.10 | — |
ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, Europe, and internationally. Its services include B cell sorting, screening and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multispecies antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning,…